# Radiofrequency Ablation Treatment of Low-Risk Papillary Thyroid Carcinomas

> **NCT07506161** · — · COMPLETED · sponsor: **Premier G Med Cardio Kft** · enrollment: 27 (actual)

## Conditions studied

- Papillary Thyroid Microcarcinoma

## Interventions

- **PROCEDURE:** Radiofrequency ablation alone

## Key facts

- **NCT ID:** NCT07506161
- **Lead sponsor:** Premier G Med Cardio Kft
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-09-09
- **Primary completion:** 2025-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2026-04-01

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07506161

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07506161, "Radiofrequency Ablation Treatment of Low-Risk Papillary Thyroid Carcinomas". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07506161. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*